Evolution of Symptoms After Sacrospinofixation With Posterior Isthmic Band
SPIP
Prospective Study of the Evolution of Symptoms After Sacrospinofixation With Posterior Isthmic Band
2 other identifiers
observational
33
1 country
1
Brief Summary
Prolapse is a condition that can cause disabling pelvic, urinary or sexual function disorders and impaired quality of life. Regarding the prolapse of the middle floor, the vaginal sacrospinofixation according to Richter is the reference technique for the suspension of the vaginal fundus. But the technique of sacrospinofixation vaginally is not without several difficulties in the short term but also in the medium and long term. Recently, anchoring devices have been developed to limit the dissection of the sacrospinous ligament and the operative exposure by the sometimes traumatic valves. The investigating team uses a technical variant in the form of an isthmic posterior strip of light weight and whose arms are sutured to the sacrospinous ligaments. The advantages of this isthmic strip are based on its small size, its very low basis weight and its wide mesh (improvement of tolerance) via a mini-invasive vaginal approach (thus allowing ambulatory care). Patient functional discomfort is the main problem related to the presence of a prolapse, therefore, the researchers wish to evaluate patient feelings following the use of this isthmic band. The researchers' hypothesis is that the sacrospinofixation technique with posterior isthmic band Bilateral Sacrospinous Colposuspension (BSC) Mesh (Agency for Medical Innovations (AMI) laboratory) improves symptoms experienced by patients with mid-level prolapse.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 10, 2019
CompletedFirst Posted
Study publicly available on registry
April 11, 2019
CompletedStudy Start
First participant enrolled
September 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2023
CompletedJanuary 11, 2024
January 1, 2023
4.2 years
April 10, 2019
January 10, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Improvement of symptoms
Percentage of patients with improvement of their symptoms on the Patient Global Impression of Improvement Index (PGI-I) scale (score 1, 2, or 3)
6 weeks postoperatively
Study Arms (1)
Sacrospinofixation
Patients with apical symptomatic prolapse ≥ II in the POP-Q classification and for whom sacrospinofixation with posterior isthmic BSC Mesh is planned
Interventions
Improvement of symptoms on the Patient Global Impression of Improvement Index (PGI-I) scale (score 1, 2, or 3) at 6 weeks postoperatively
Eligibility Criteria
Patients with apical symptomatic prolapse ≥ II in the Pelvic Organ Prolapse Quantification (POP-Q) classification and for whom sacrospinofixation with posterior isthmic Bilateral Sacrospinous Colposuspension (BSC) Mesh is planned
You may qualify if:
- women over 18
- apical prolapse requiring surgical correction of grade II or greater in the Pelvic Organ Prolapse Quantification (POP-Q) classification
- patients who wish an intervention because of the discomfort caused by prolapse
- sacrospinofixation procedure with posterior isthmic band Bilateral Sacrospinous Colposuspension (BSC) Mesh provided
- person having expressed his non-opposition
You may not qualify if:
- apical prolapse of stage \< II in the Pelvic Organ Prolapse Quantification (POP-Q) classification, and prolapse without functional discomfort
- disorders leading to an unacceptable risk of postoperative complications sought during the interrogation of the patient (disorders of blood coagulation, disorders of the immune system, progressive diseases ....)
- reduced mobility of the lower limbs (not allowing positioning for surgery)
- pregnancy or any plans for pregnancy during the study period
- evolutionary or latent infection
- known hypersensitivity to polypropylene
- inability to understand the information given
- person deprived of liberty, under guardianship.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de gynecologie Hôpital Femme mère enfant
Bron, 69500, France
Study Officials
- PRINCIPAL INVESTIGATOR
Gautier CHENE, Ph.D.
Hospices Civils de Lyon, Hôpital Femme Mère Enfant
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 10, 2019
First Posted
April 11, 2019
Study Start
September 2, 2019
Primary Completion
November 15, 2023
Study Completion
November 15, 2023
Last Updated
January 11, 2024
Record last verified: 2023-01